Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/700841/000070084119000004/form8kpressrel122918.htm
March 2023
March 2023
January 2023
December 2022
December 2022
November 2022
October 2022
August 2022
August 2022
April 2022
RCM Technologies, Inc.
|
Tel: 856.356.4500
|
Corporate Contacts:
|
2500 McClellan Avenue
|
Fax: 856.356.4600
|
Bradley S. Vizi
|
Pennsauken, NJ 08109
|
info@rcmt.com
|
Executive Chairman
|
www.rcmt.com
|
Kevin D. Miller
|
|
Chief Financial Officer
|
Thirteen Week Periods Ended
|
||||
December 29,
2018
|
December 30,
2017
|
|||
(Unaudited)
|
||||
Revenues
|
$55,271
|
$51,057
|
||
Cost of services
|
42,239
|
38,253
|
||
Gross profit
|
13,032
|
12,804
|
||
Selling, general and administrative
|
10,477
|
10,293
|
||
Depreciation and amortization of property and equipment
|
326
|
512
|
||
Amortization of acquired intangible assets
|
85
|
16
|
||
Severance, professional fees, office closures and other
|
200
|
1,447
|
||
Tax credit professional fees
|
371
|
259
|
||
Change in contingent consideration
|
-
|
-
|
||
Goodwill impairment
|
-
|
3,478
|
||
Operating income (loss)
|
1,573
|
(3,201
|
)
|
|
Other expense, net
|
(517
|
)
|
(154
|
)
|
Income before income (loss) taxes
|
1,056
|
(3,355
|
)
|
|
Income tax expense (benefit)
|
457
|
(3,606
|
)
|
|
Net income
|
$599
|
$251
|
||
Diluted net earnings per share data
|
$0.05
|
$0.02
|
Fifty-Two Week Periods Ended
|
||||
December 29,
2018
|
December 30,
2017
|
|||
(Unaudited)
|
||||
Revenues
|
$200,352
|
$186,737
|
||
Cost of services
|
151,042
|
138,350
|
||
Gross profit
|
49,310
|
48,387
|
||
Selling, general and administrative
|
40,386
|
40,385
|
||
Depreciation and amortization of property and equipment
|
1,442
|
1,691
|
||
Amortization of acquired intangible assets
|
125
|
66
|
||
Severance, professional fees, office closures and other
|
1,571
|
1,447
|
||
Tax credit professional fees
|
371
|
259
|
||
Change in contingent consideration
|
-
|
781
|
||
Goodwill impairment
|
-
|
3,478
|
||
Operating income
|
5,415
|
280
|
||
Other expense, net
|
(1,507
|
)
|
(525
|
)
|
Income (loss) before income taxes
|
3,908
|
(245
|
)
|
|
Income tax expense (benefit)
|
1,193
|
(2,255
|
)
|
|
Net income
|
$2,715
|
$2,010
|
||
Diluted net earnings per share data
|
$0.22
|
$0.17
|
December 29,
2018
|
December 30,
2017
|
|||
(Unaudited)
|
||||
Cash and cash equivalents
|
$482
|
$2,851
|
||
Accounts receivable, net
|
$52,335
|
$46,080
|
||
Total current assets
|
$58,811
|
$55,639
|
||
Total assets
|
$81,510
|
$73,279
|
||
Total current liabilities
|
$23,188
|
$22,188
|
||
Borrowing under line of credit
|
$27,540
|
$27,279
|
||
Net debt (borrowings less cash)
|
$27,058
|
$24,428
|
||
Total liabilities
|
$54,311
|
$51,248
|
||
Stockholders’ equity
|
$27,199
|
$22,031
|
Thirteen
Week Periods Ended
|
Fifty-Two
Week Periods Ended
|
|||||||
December 29,
2018
|
December 30,
2017
|
December 29,
2018
|
December 30,
2017
|
|||||
GAAP net income
|
$599
|
$251
|
$2,715
|
$2,010
|
||||
Income tax expense (benefit)
|
457
|
(3,606
|
)
|
1,193
|
(2,255
|
)
|
||
Interest expense
|
500
|
181
|
1,471
|
590
|
||||
Depreciation of property and equipment
|
326
|
512
|
1,442
|
1,691
|
||||
Amortization of acquired intangible assets
|
85
|
16
|
125
|
66
|
||||
EBITDA (non-GAAP)
|
$1,967
|
($2,646
|
)
|
$6,946
|
$2,102
|
|||
Adjustments
|
||||||||
Severance, professional fees,
office
closures and other charges
|
200
|
1,447
|
1,571
|
1,447
|
||||
Tax credit professional fees
|
371
|
259
|
371
|
259
|
||||
Change in contingent consideration
|
-
|
-
|
-
|
781
|
||||
Goodwill impairment
|
-
|
3,478
|
-
|
3,478
|
||||
Loss (gain) on foreign currency
transactions
|
17
|
(27
|
)
|
36
|
(65
|
)
|
||
Adjusted EBITDA (non-GAAP)
|
$2,555
|
$2,511
|
$8,924
|
$8,002
|
Thirteen Week Periods Ended
|
|||||
December 29,
2018
|
December 30,
2017
|
||||
(Unaudited)
|
|||||
Net income
|
$599
|
$251
|
|||
Adjustments to reconcile net income to cash
used in operating activities
|
2,167
|
1,634
|
|||
Changes in operating assets and liabilities:
|
|||||
Accounts receivable
|
(6,017
|
)
|
(4,141
|
)
|
|
Prepaid expenses and other current assets
|
423
|
(523
|
)
|
||
Net of transit accounts receivable and payable
|
(156
|
)
|
359
|
||
Accounts payable and accrued expenses
|
1,240
|
995
|
|||
Accrued payroll and related costs
|
430
|
668
|
|||
Income taxes payable
|
(814
|
)
|
(1,128
|
)
|
|
Total adjustments
|
(2,727
|
)
|
(2,136
|
)
|
|
Cash used in operating activities
|
($2,128
|
)
|
($1,885
|
)
|
|
Net cash used in investing activities
|
(1,160
|
)
|
(1,060
|
)
|
|
Net cash provided by financing activities
|
3,081
|
4,795
|
|||
Effect of exchange rate changes
|
(21
|
)
|
176
|
||
(Decrease) increase in cash and cash equivalents
|
($228
|
)
|
$2,026
|
Fifty-Two Week Periods Ended
|
|||||
December 29,
2018
|
December 30,
2017
|
||||
(Unaudited)
|
|||||
Net income
|
$2,715
|
$2,010
|
|||
Adjustments to reconcile net income to cash
(used in) provided by operating activities
|
4,694
|
4,660
|
|||
Changes in operating assets and liabilities:
|
|||||
Accounts receivable
|
(7,681
|
)
|
(459
|
)
|
|
Prepaid expenses and other current assets
|
(170
|
)
|
(293
|
)
|
|
Net of transit accounts receivable and payable
|
(1,716
|
)
|
(830
|
)
|
|
Accounts payable and accrued expenses
|
1,021
|
(318
|
)
|
||
Accrued payroll and related costs
|
1,335
|
483
|
|||
Income taxes payable
|
(262
|
)
|
(182
|
)
|
|
Total adjustments
|
(2,779
|
)
|
3,061
|
||
Cash (used in) provided by operating activities
|
(64
|
)
|
$5,071
|
||
Net cash used in investing activities
|
(2,583
|
)
|
(1,803
|
)
|
|
Net cash provided by (used in) financing activities
|
346
|
(826
|
)
|
||
Effect of exchange rate changes
|
(68
|
)
|
130
|
||
(Decrease) increase in cash and cash equivalents
|
($2,369
|
)
|
$2,572
|
Thirteen Week Period Ended December 29, 2018
|
||||||||
Engineering
|
Specialty
Health Care
|
Information
Technology
|
Consolidated
|
|||||
Revenue
|
$23,666
|
$23,065
|
$8,540
|
$55,271
|
||||
Cost of services
|
17,781
|
18,039
|
6,419
|
42,239
|
||||
Gross Profit
|
$5,885
|
$5,026
|
$2,121
|
$13,032
|
||||
Gross Profit Margin
|
24.9
|
%
|
21.8
|
%
|
24.8
|
%
|
23.6
|
%
|
Thirteen Week Period Ended December 30, 2017
|
||||||||
Engineering
|
Specialty
Health Care
|
Information
Technology
|
Consolidated
|
|||||
Revenue
|
$21,236
|
$22,104
|
$7,717
|
$51,057
|
||||
Cost of services
|
15,745
|
16,750
|
5,758
|
38,253
|
||||
Gross Profit
|
$5,491
|
$5,354
|
$1,959
|
$12,804
|
||||
Gross Profit Margin
|
25.9
|
%
|
24.2
|
%
|
25.4
|
%
|
25.1
|
%
|
Fifty-Two Week Period Ended December 29, 2018
|
||||||||
Engineering
|
Specialty
Health Care
|
Information
Technology
|
Consolidated
|
|||||
Revenue
|
$86,078
|
$83,663
|
$30,611
|
$200,352
|
||||
Cost of services
|
63,488
|
64,860
|
22,694
|
151,042
|
||||
Gross Profit
|
$22,590
|
$18,803
|
$7,917
|
$49,310
|
||||
Gross Profit Margin
|
26.2
|
%
|
22.5
|
%
|
25.9
|
%
|
24.6
|
%
|
Fifty-Two Week Period Ended December 30, 2017
|
||||||||
Engineering
|
Specialty
Health Care
|
Information
Technology
|
Consolidated
|
|||||
Revenue
|
$82,753
|
$71,316
|
$32,668
|
$186,737
|
||||
Cost of services
|
60,352
|
53,801
|
24,197
|
138,350
|
||||
Gross Profit
|
$22,401
|
$17,515
|
$8,471
|
$48,387
|
||||
Gross Profit Margin
|
27.1
|
%
|
24.6
|
%
|
25.9
|
%
|
25.9
|
%
|
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/700841/000070084119000004/form8kpressrel122918.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Rcm Technologies Inc.
Rcm Technologies Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Rcm Technologies Inc provided additional information to their SEC Filing as exhibits
Ticker: RCMTEvents:
CIK: 700841
Form Type: 8-K Corporate News
Accession Number: 0000700841-19-000004
Submitted to the SEC: Wed Mar 06 2019 4:25:22 PM EST
Accepted by the SEC: Wed Mar 06 2019
Period: Wednesday, March 6, 2019
Industry: Help Supply Services